1. Home
  2. SND vs CGEN Comparison

SND vs CGEN Comparison

Compare SND & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

N/A

Current Price

$5.19

Market Cap

205.6M

Sector

Industrials

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

N/A

Current Price

$2.61

Market Cap

191.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SND
CGEN
Founded
2011
1993
Country
United States
Israel
Employees
318
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
191.1M
IPO Year
2016
2001

Fundamental Metrics

Financial Performance
Metric
SND
CGEN
Price
$5.19
$2.61
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
243.0K
306.7K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
2.81%
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$330,153,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
$34.67
N/A
Revenue Growth
6.03
N/A
52 Week Low
$1.88
$1.30
52 Week High
$5.92
$3.24

Technical Indicators

Market Signals
Indicator
SND
CGEN
Relative Strength Index (RSI) 60.50 55.21
Support Level $4.55 $2.54
Resistance Level $5.29 $2.99
Average True Range (ATR) 0.22 0.13
MACD 0.04 -0.00
Stochastic Oscillator 77.17 50.39

Price Performance

Historical Comparison
SND
CGEN

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics. The company has two reportable segments, Sand and SmartSystems. It derives maximum revenue from Sand segment, which includes both frac sand sales and IPS sales. Geographically, the company derives maximum revenue from United States, followed by Canada.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: